Anti-TTC39C monoclonal antibody

Pre-made anti-TTC39C monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TTC39C/TTC39C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2203-Ab-1/ GM-Tg-hg-IP2203-Ab-2Anti-Human TTC39C monoclonal antibodyHuman
GM-Tg-rg-IP2203-Ab-1/ GM-Tg-rg-IP2203-Ab-2Anti-Rat TTC39C monoclonal antibodyRat
GM-Tg-mg-IP2203-Ab-1/ GM-Tg-mg-IP2203-Ab-2Anti-Mouse TTC39C monoclonal antibodyMouse
GM-Tg-cynog-IP2203-Ab-1/ GM-Tg-cynog-IP2203-Ab-2Anti-Cynomolgus/ Rhesus macaque TTC39C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2203-Ab-1/ GM-Tg-felg-IP2203-Ab-2Anti-Feline TTC39C monoclonal antibodyFeline
GM-Tg-cang-IP2203-Ab-1/ GM-Tg-cang-IP2203-Ab-2Anti-Canine TTC39C monoclonal antibodyCanine
GM-Tg-bovg-IP2203-Ab-1/ GM-Tg-bovg-IP2203-Ab-2Anti-Bovine TTC39C monoclonal antibodyBovine
GM-Tg-equg-IP2203-Ab-1/ GM-Tg-equg-IP2203-Ab-2Anti-Equine TTC39C monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2203-Ab-1/ GM-Tg-hg-IP2203-Ab-2; GM-Tg-rg-IP2203-Ab-1/ GM-Tg-rg-IP2203-Ab-2;
GM-Tg-mg-IP2203-Ab-1/ GM-Tg-mg-IP2203-Ab-2; GM-Tg-cynog-IP2203-Ab-1/ GM-Tg-cynog-IP2203-Ab-2;
GM-Tg-felg-IP2203-Ab-1/ GM-Tg-felg-IP2203-Ab-2; GM-Tg-cang-IP2203-Ab-1/ GM-Tg-cang-IP2203-Ab-2;
GM-Tg-bovg-IP2203-Ab-1/ GM-Tg-bovg-IP2203-Ab-2; GM-Tg-equg-IP2203-Ab-1/ GM-Tg-equg-IP2203-Ab-2
Products NameAnti-TTC39C monoclonal antibody
Formatmab
Target NameTTC39C
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TTC39C monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2203-Ag-1Recombinant multi-species TT39C/ TTC39C/ C18orf17 protein


    Target information

    Target IDGM-IP2203
    Target NameTTC39C
    Gene ID125488,72747,686179,701560,480172,101097428,532895,100063448
    Gene Symbol and Synonyms1700008N02Rik,2810439F02Rik,C18orf17,HsT2697,TTC39C
    Uniprot AccessionQ8N584,Q0VGK2
    Uniprot Entry NameTT39C_HUMAN,TT39C_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168234
    Target ClassificationN/A

    The target: TTC39C, gene name: TTC39C, also named as C18orf17, HsT2697. Predicted to be involved in cilium assembly and otolith morphogenesis. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.